In addition to amphetamine, methylphenidate is used to treat the EDS associated with narcolepsy. Methylphenidate is mostly commonly known as the primary treatment for children with attention-deficit hyperactivity disorder (ADHD).5 The mechanism of action of methylphenidate is much simpler than that of ...
Future treatments Current treatments for human narcolepsy are symptom- atically based. However, given the major developments in understanding the neurobiological basis of the condition, new therapies are likely to emerge. There are currently several focuses for future treatment Symptomatic neurotransmitters ...
At present, since there is no cure for narcolepsy-cataplexy, treatment goals include control of symptoms and optimization of lifestyle and psychosocial function. Successful treatment includes both behavioral and pharmacological treatments. Behavioral treatment includes developing healthy sleep habits and avoid...
The Journal of Headache and Pain (2023) 24:121 https://doi.org/10.1186/s10194-023-01660-8 The Journal of Headache and Pain CONSENSUS ARTICLE Open Access Current treatment options for cluster headache: limitations and the unmet need for better and specific treatments—a consensus ...
Although no head-to-head treatment trials exist in trauma-associated sleep disorder, clonazepam has been observed to be less effective in treating RBD compared to established treatments for PTSD such as prazosin or imagery rehearsal therapy [124]. Patients with type 1 narcolepsy who have RBD also...
(33%).88 Despite differences in frequency of episodes, the severity of sleep paralysis did not differ between the two groups.88 Hypocretin deficiency is believed to be an autoimmune response,87 with almost all narcolepsy with cataplexy patients testing positive for the human leukocyte antigen ...
Current treatments for clinical conditions of disturbed arousal or sleep primarily target the aminergic, cholinergic, or GABAergic neurotransmission of the 'bottom-up' path- way pharmacologically. This pharmacological approach is widely used with some success, but with important side effects and limited...
6.Novel Systemic Treatments for Brain Metastases From Lung Cancer 机译:肺癌脑转移的新型全身治疗 作者:Thapa Bicky;Lauko Adam;Desai Kunal;Venur Vyshak Alva;Ahluwalia Manmeet S. 期刊名称:《Current treatment options in neurology》 | 2018年第11期 关键词: Brain metastases; Lung cancer; EGFR; ...
This may be followed by weekly doses for 6–12 weeks, or a slow oral taper of prednisone. Plasmapheresis every second day for 5–7 treatments can also be trialed upfront or used in treatment-resistant cases. In syndromes associated with intracellular antigen-directed antibodies, neuronal injury...
Current treatments for clinical conditions of disturbed arousal or sleep primarily target the aminergic, cholinergic, or GABAergic neurotransmission of the 'bottom-up' path- way pharmacologically. This pharmacological approach is widely used with some success, but with important side effects and limited...